Ophthalmology · Baltimore, MD
NPI
1508327420
Since 2019
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
22 S Greene St Rm N3e09
Baltimore, MD, 21201
Phone (410) 328-6110
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,421
108 services
Medicare patients, 2024
75
Average age 76
Drug cost, 2024
$367K
4,014 prescriptions
Company payments, 2025
$14.42
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen P Yoon was code 92012 (ophthalmological e&m), 39 times for 39 patients. In total Stephen P Yoon billed 108 services in 13 codes, and Medicare paid $7,421.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-09-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92012 Ophthalmological E&M | Office | 39 | 39 | $55.41 | $2,161 |
| 92133 Computerized Ophthalmic Imaging | Office | 12 | 12 | $21.04 | $253 |
| 92014 Ophthalmological E&M | Office | 11 | 11 | $102.94 | $1,132 |
Medicare prescription drug claims, 2024
In 2024, the drug Stephen P Yoon prescribed most often to Medicare patients was Latanoprost, with 1,062 prescriptions and refills. In total Stephen P Yoon wrote 4,014 Medicare prescriptions that cost $367K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 1,062 | 2,187 | 377 | $13K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 615 | 1,405 | 227 | $10K |
| Brimonidine Tartrate Generic | 450 | 852 | 160 | $10K |
| Prednisolone Acetate Generic | 290 | 392 | 198 | $12K |
| Timolol Maleate Generic | 252 | 551 | 100 | $5,466 |
| Dorzolamide Hcl Generic | 206 | 429 | 73 | $4,461 |
| Ketorolac Tromethamine Generic | 107 | 131 | 84 | $2,517 |
| Dorzolamide-Timolol Dorzolamide/Timolol/Pf | 83 | 125 | 26 | $12K |
| Lumigan Bimatoprost | 79 | 143 | 29 | $38K |
| Rocklatan Netarsudil Mesylat/Latanoprost | 69 | 119 | 20 | $38K |
| Combigan Brimonidine Tartrate/Timolol | 66 | 123 | 21 | $28K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 62 | 108 | 20 | $9,294 |
| Moxifloxacin Moxifloxacin Hcl | 59 | 59 | 55 | $686 |
| Rhopressa Netarsudil Mesylate | 58 | 92 | 22 | $29K |
| Travoprost Generic | 55 | 114 | 20 | $9,546 |
Brand drugs: 1,164 claims; generic drugs: 2,850 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephen P Yoon $14.42 ($14.42 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $14.42.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $14.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.